Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


vaccine soon?
Aug 26, 2003

dear doc, thanks for all the info on this site. I appreciate your thorough answers and good humor. for me, and I'm sure thousands of others, it has been a great source of info and comfort.

now, pull your crystal ball out of your black bag and give me your best educated guess. What are the chances(50/50, 75/25 against, 75/25 in favor etc.) of a therapeutic vaccine being developed, in the next five years, to prolong the period that an HIVer can go without taking meds.

I realize that the meds have come a long way in the last few years, but I'm hoping that I can postpone the inevitable for as long as possible.

P.S. CD4 325, still waiting for VL but last one was 3000

Is this an unrealistic hope?

Response from Dr. Pierone

I really believe that a therapeutic vaccine will become part of HIV treatment of the future unless this strategy is leapfrogged by gene therapy. At the last Retrovirus meeting there were several proof of concept studies presented on therapeutic vaccination. In short, HIV-infected patients were given therapeutic vaccines and most showed evidence of enhanced immune response to HIV. A strategic interruption was then done and those who responded to the vaccine had a greater delay in viral rebound compared to those in whom the vaccine "did not take". Thus, these studies suggested that vaccination augments immune response and this likely translates into a measurable antiviral effect.

There are some very important caveats however. There were some mild side effects from the vaccine, and the immunologic response was very modest, especially compared to HIV meds.

Of more concern, at this same meeting, a case of HIV superinfection was reported in an individual that had been treated during acute infection with HAART and an STI protocol. He had documented broad immune response to HIV and despite this was still able to acquire infection with a closely related clade B strain of virus. So, immunologic activity and protection against HIV confers only partial protection at best.

So, to answer your question. Progress will continue to be made in therapeutic vaccine development over the next 5 years, but will probably not result in a licensed product in that time period. There may be access through clinical trials in this time period so stay tuned.



Previous
Start HAART now or wait?
Next
Reducing Meds?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement